Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oximes of oxymorphone, naltrexone and naloxone as potent, selective opioid receptor agonists and antagonists

Oximes of oxymorphone, naltrexone and naloxone as potent, selective opioid receptor agonists and antagonists

US Patent 4889860 · Granted Dec 26, 1989

Estimated economic value: $1,289,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Indole-type derivatives as inhibitors of p38 kinase2009
Indole-type derivatives as inhibitors of p38 kinase2007
Indole-type derivatives as inhibitors of p38 kinase2007
Indole-type derivatives as inhibitors of p38 kinase2007
Piperidine/piperazine-type inhibitors of p38 kinase2007
Benzofuran derivatives as inhibitors of p38-α kinase2007
Compounds and methods to treat cardiac failure and other disorders2007
Indole-type derivatives as inhibitors of p38 kinase2005
Indole-type derivatives as inhibitors of p38 kinase2005
Piperidine/piperazine-type inhibitors of p38 kinase2004
Compounds and methods to treat cardiac failure and other disorders2003
Inhibitors of p38-a kinase2003